Literature DB >> 25960955

Bioassays for TSH Receptor Antibodies: Quo Vadis?

George J Kahaly1.   

Abstract

Entities:  

Year:  2015        PMID： 25960955      PMCID： PMC4404890          DOI： 10.1159/000375445

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN： 2235-0640


× No keyword cloud information.
  21 in total

1.  Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.

Authors:  M Schott; W B Minich; H S Willenberg; C Papewalis; J Seissler; J Feldkamp; A Bergmann; W A Scherbaum; N G Morgenthaler
Journal:  Horm Metab Res       Date:  2005-12       Impact factor: 2.936

2.  A 2013 European survey of clinical practice patterns in the management of Graves' disease.

Authors:  L Bartalena; H B Burch; K D Burman; G J Kahaly
Journal:  Clin Endocrinol (Oxf)       Date:  2015-01-09       Impact factor: 3.478

3.  A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.

Authors:  S D Lytton; K A Ponto; M Kanitz; N Matheis; L D Kohn; G J Kahaly
Journal:  J Clin Endocrinol Metab       Date:  2010-03-17       Impact factor: 5.958

Review 4.  Bioassays for TSH-receptor autoantibodies: an update.

Authors:  Simon D Lytton; George J Kahaly
Journal:  Autoimmun Rev       Date:  2010-08-31       Impact factor: 9.754

5.  A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease.

Authors:  Cesidio Giuliani; Dominique Cerrone; Norikazu Harii; Mark Thornton; Leonard D Kohn; Nilesh M Dagia; Emilio Fiore; Ines Bucci; Tyler Chamblin; Paolo Vitti; Fabrizio Monaco; Giorgio Napolitano
Journal:  J Clin Endocrinol Metab       Date:  2012-04-10       Impact factor: 5.958

Review 6.  The thyrotropin receptor in Graves' disease.

Authors:  Basil Rapoport; Sandra M McLachlan
Journal:  Thyroid       Date:  2007-10       Impact factor: 6.568

7.  Analytical performance and clinical utility of a bioassay for thyroid-stimulating immunoglobulins.

Authors:  Johannes J Leschik; Tanja Diana; Paul D Olivo; Jochem König; Ulrike Krahn; Yunsheng Li; Michael Kanitz; George J Kahaly
Journal:  Am J Clin Pathol       Date:  2013-02       Impact factor: 2.493

8.  TSH receptor - autoantibody interactions.

Authors:  B Rees Smith; J Sanders; M Evans; T Tagami; J Furmaniak
Journal:  Horm Metab Res       Date:  2009-06       Impact factor: 2.936

9.  Characterization of thyrotropin receptor antibody-induced signaling cascades.

Authors:  Syed A Morshed; Rauf Latif; Terry F Davies
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

10.  Intermethod variability in TSH-receptor antibody measurement: implication for the diagnosis of Graves disease and for the follow-up of Graves ophthalmopathy.

Authors:  Catherine Massart; Rémy Sapin; Jacqueline Gibassier; Arnaud Agin; Michèle d'Herbomez
Journal:  Clin Chem       Date:  2008-11-21       Impact factor: 8.327
View more
  17 in total

1.  Unexpected cause of fever in a patient with untreated HIV.

Authors:  Mamta Chhetri; Stasia Miaskiewicz; Taylor Abegg Lawrence; Anastasios Kapetanos
Journal:  BMJ Case Rep       Date:  2018-07-03

2.  TSH Receptor Antibodies (TRAb) Assay: An Underutilized Test in India.

Authors:  Jubbin Jagan Jacob
Journal:  Indian J Endocrinol Metab       Date:  2022-04-27

3.  Thyrotropin receptor antibody immunoassays may not be reliable in confirming diagnosis of Painless Thyroiditis.

Authors:  D Sanyal; S Chatterjee
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Oct-Dec       Impact factor: 0.877

4.  Predictive Factors for Changes in Quality of Life after Steroid Treatment for Active Moderate-to-Severe Graves' Orbitopathy: A Prospective Trial.

Authors:  Elena Hoppe; Alan Chun Hong Lee; David Hoppe; George J Kahaly
Journal:  Eur Thyroid J       Date:  2020-07-02

5.  A Novel Long-Term Graves' Disease Animal Model Confirmed by Functional Thyrotropin Receptor Antibodies.

Authors:  Tanja Diana; Hans-Peter Holthoff; Julia Fassbender; Christian Wüster; Michael Kanitz; George J Kahaly; Martin Ungerer
Journal:  Eur Thyroid J       Date:  2020-07-23

6.  TSH Receptor Antibody Functionality and Nomenclature.

Authors:  George J Kahaly; Tanja Diana
Journal:  Front Endocrinol (Lausanne)       Date:  2017-02-15       Impact factor: 5.555

Review 7.  Graves' hyperthyroidism in pregnancy: a clinical review.

Authors:  Caroline T Nguyen; Elizabeth B Sasso; Lorayne Barton; Jorge H Mestman
Journal:  Clin Diabetes Endocrinol       Date:  2018-03-01

8.  Nivolumab-induced thyroid dysfunction lacking antithyroid antibody is frequently evoked in Japanese patients with malignant melanoma.

Authors:  Seiichi Yano; Kenji Ashida; Hiromi Nagata; Kenji Ohe; Naoko Wada; Yukina Takeichi; Yuki Hanada; Yuta Ibayashi; Lixiang Wang; Shohei Sakamoto; Ryuichi Sakamoto; Hiroshi Uchi; Motoaki Shiratsuchi; Masutaka Furue; Masatoshi Nomura; Yoshihiro Ogawa
Journal:  BMC Endocr Disord       Date:  2018-06-08       Impact factor: 2.763

9.  Diagnostic accuracy of a new fluoroenzyme immunoassay for the detection of TSH receptor autoantibodies in Graves' disease.

Authors:  Danilo Villalta; Federica D'Aurizio; Mirella Da Re; Debora Ricci; Francesco Latrofa; Renato Tozzoli
Journal:  Auto Immun Highlights       Date:  2018-02-12

10.  2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism.

Authors:  George J Kahaly; Luigi Bartalena; Lazlo Hegedüs; Laurence Leenhardt; Kris Poppe; Simon H Pearce
Journal:  Eur Thyroid J       Date:  2018-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.